Aptamer Sciences Shares Owned By Insiders vs. Net Income

291650 Stock  KRW 1,816  73.00  3.86%   
Based on Aptamer Sciences' profitability indicators, Aptamer Sciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Aptamer Sciences' ability to earn profits and add value for shareholders.
For Aptamer Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aptamer Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aptamer Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aptamer Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aptamer Sciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Aptamer Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptamer Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptamer Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aptamer Sciences Net Income vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Aptamer Sciences's current stock value. Our valuation model uses many indicators to compare Aptamer Sciences value to that of its competitors to determine the firm's financial worth.
Aptamer Sciences is number one stock in shares owned by insiders category among its peers. It is rated below average in net income category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptamer Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptamer Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Aptamer Net Income vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Aptamer Sciences

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
33.00 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Aptamer Sciences

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(3.83 B)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Aptamer Net Income Comparison

Aptamer Sciences is currently under evaluation in net income category among its peers.

Aptamer Sciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Aptamer Sciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aptamer Sciences will eventually generate negative long term returns. The profitability progress is the general direction of Aptamer Sciences' change in net profit over the period of time. It can combine multiple indicators of Aptamer Sciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea. Aptamer Sciences is traded on Korean Securities Dealers Automated Quotations in South Korea.

Aptamer Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Aptamer Sciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aptamer Sciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aptamer Sciences' important profitability drivers and their relationship over time.

Use Aptamer Sciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptamer Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptamer Sciences will appreciate offsetting losses from the drop in the long position's value.

Aptamer Sciences Pair Trading

Aptamer Sciences Pair Trading Analysis

The ability to find closely correlated positions to Aptamer Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptamer Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptamer Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptamer Sciences to buy it.
The correlation of Aptamer Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptamer Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptamer Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptamer Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Aptamer Sciences position

In addition to having Aptamer Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Chemicals Makers Thematic Idea Now

Chemicals Makers
Chemicals Makers Theme
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Aptamer Stock

To fully project Aptamer Sciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aptamer Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aptamer Sciences' income statement, its balance sheet, and the statement of cash flows.
Potential Aptamer Sciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Aptamer Sciences investors may work on each financial statement separately, they are all related. The changes in Aptamer Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aptamer Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.